Cyclosporin acts by inhibiting the proliferation of:
**Core Concept**
Cyclosporin, a calcineurin inhibitor, is an immunosuppressive medication that plays a crucial role in preventing organ rejection in transplant patients. Its mechanism of action is centered around the inhibition of T-cell activation.
**Why the Correct Answer is Right**
Cyclosporin primarily targets the calcineurin pathway, which is essential for the activation of T-cells. By inhibiting calcineurin, cyclosporin prevents the transcription of IL-2, a key cytokine involved in T-cell proliferation. This results in the suppression of the immune response, thereby preventing organ rejection. The immunosuppressive effects of cyclosporin are primarily mediated through its binding to cyclophilin, which is then inhibited from binding to calcineurin.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as cyclosporin does not primarily act on B-cells, which are a different type of immune cell.
**Option B:** This option is incorrect as cyclosporin does not primarily act on macrophages, which are a type of immune cell involved in the phagocytosis of pathogens.
**Option C:** This option is incorrect as cyclosporin does not primarily act on the complement system, which is a part of the innate immune system.
**Clinical Pearl / High-Yield Fact**
Cyclosporin is a potent immunosuppressant that requires careful monitoring to prevent adverse effects such as nephrotoxicity and hypertension. Patients on cyclosporin therapy should have regular blood tests to monitor their kidney function and blood pressure.
**Correct Answer: D. T-cells. Inhibiting the proliferation of T-cells.**